MARKET

VRTX

VRTX

Vertex Pharmaceuticals Inc
NASDAQ
484.15
+15.77
+3.37%
After Hours: 481.67 -2.48 -0.51% 19:47 01/07 EST
OPEN
469.13
PREV CLOSE
468.38
HIGH
487.52
LOW
467.46
VOLUME
1.72M
TURNOVER
--
52 WEEK HIGH
519.68
52 WEEK LOW
362.50
MARKET CAP
122.84B
P/E (TTM)
34.02
1D
5D
1M
3M
1Y
5Y
1D
A Glimpse Into The Expert Outlook On Vertex Pharmaceuticals Through 11 Analysts
Benzinga · 9h ago
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should Know
NASDAQ · 14h ago
Vertex Pharmaceuticals Price Target Cut to $535.00/Share From $546.00 by UBS
Dow Jones · 14h ago
Vertex Pharmaceuticals Coverage Assumed by UBS at Buy
Dow Jones · 14h ago
VERTEX PHARMACEUTICALS INC <VRTX.O>: UBS CUTS TARGET PRICE TO $535 FROM $546
Reuters · 14h ago
Analysts Offer Insights on Healthcare Companies: BeOne Medicines (ONC) and Vertex Pharmaceuticals (VRTX)
TipRanks · 14h ago
UBS Assumes Vertex Pharmaceuticals at Buy, Lowers Price Target of $535
Benzinga · 14h ago
Is Vertex Pharmaceuticals (VRTX) Pricing Look Attractive After Strong Multi Year Share Gains
Simply Wall St · 18h ago
More
About VRTX
Vertex Pharmaceuticals Incorporated is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases, with a focus on specialty markets. It has seven approved medicines: five that treat the underlying cause of cystic fibrosis (CF), one that treats severe sickle cell disease (SCD) and transfusion dependent beta thalassemia (TDT), and one that treats moderate-to-severe acute pain. Its pipeline includes clinical-stage programs in CF, SCD, beta thalassemia, acute and peripheral neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy and other autoimmune renal diseases and cytopenias, type 1 diabetes, myotonic dystrophy type 1, and autosomal dominant polycystic kidney disease. Its marketed medicines are TRIKAFTA/KAFTRIO (elexacaftor/tezacaftor/ivacaftor and ivacaftor), SYMDEKO/SYMKEVI (elexacaftor/tezacaftor/ivacaftor and ivacaftor), ORKAMBI (lumacaftor/ivacaftor), and KALYDECO (ivacaftor).

Webull offers Vertex Pharmaceuticals Inc stock information, including NASDAQ: VRTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRTX stock methods without spending real money on the virtual paper trading platform.